Trademark: 90531826
Status Date
Monday, February 12, 2024
Filing Date
Wednesday, February 17, 2021
Published for Opposition
Tuesday, July 27, 2021
5 Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Feb 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2024
Sou Extension 5 Granted
Jan 30, 2024
Sou Extension 5 Filed
Feb 12, 2024
Case Assigned To Intent To Use Paralegal
Jan 30, 2024
Sou Teas Extension Received
Aug 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 7, 2023
Sou Extension 4 Granted
Aug 7, 2023
Sou Extension 4 Filed
Aug 7, 2023
Sou Teas Extension Received
Jan 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2023
Sou Extension 3 Granted
Jan 25, 2023
Sou Extension 3 Filed
Jan 25, 2023
Sou Teas Extension Received
Sep 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2022
Sou Extension 2 Granted
Sep 1, 2022
Sou Extension 2 Filed
Sep 1, 2022
Sou Teas Extension Received
Feb 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2022
Sou Extension 1 Granted
Feb 10, 2022
Sou Extension 1 Filed
Feb 10, 2022
Sou Teas Extension Received
Sep 21, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 27, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 27, 2021
Published For Opposition
Jul 7, 2021
Notification Of Notice Of Publication E-Mailed
Jun 22, 2021
Approved For Pub - Principal Register
Jun 20, 2021
Assigned To Examiner
May 19, 2021
New Application Office Supplied Data Entered
Feb 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24